Latest1 information on COVID-19
©2022 Stanford Medicine
Recruiting
I'm InterestedTrial ID: NCT04994249
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
Redlich Professor, Professor of Anesthesiology, Perioperative, and Pain Medicine and, by courtesy, of Neurology
Inclusion Criteria:
- 1) Inclusion criteria: Adults (18-80 years; ~64% female expected based on clinic
distribution) with chronic MSP as categorized by the World Health Organization (WHO).
Exclusion Criteria:
- 1) Chronic musculoskeletal pain (MSP) explained by inflammatory disease (e.g.,
rheumatoid arthritis, lupus) or CP with a primary diagnosis other than chronic MSP
(e.g., neuropathic pain), (2) significant cognitive impairment, (3) MRI
contraindication, (4) medical or psychiatric problems interfering with the study, (5)
current medicolegal factors (e.g., open disability claim), (6) plans for surgery
during the study, (7) pregnancy and (8) Children under the age of 18 will not be
included in the study.
Recruiting
I'm Interested
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Anne Cunniffe Marcy, MSBH
650-721-6931